Approval · Notice of Compliance 35924 · 2025
SPIKEVAX: Notice of Compliance 35924
Issued June 6, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35924
- Date
- June 6, 2025
- Company
- Moderna Biopharma Canada CorporationToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of new manufacturing sites for the drug substance and drug product. Addition of new presentation
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SPIKEVAX | Not yet assigned | — |
Medicinal ingredients
- *SARSCOV2 S-PROTEIN MRNA, 5'(M7G-5'-PPP-5'-GM), 3'POLYA 0.32 MG per ML
- *SARSCOV2 S-PROTEIN MRNA, 5'(M7G-5'-PPP-5'-GM), 3'POLYA 50 MCG per 0.5ML